VisualSonics sees 200th install of micro-ultrasound system

Toronto, Ontario-based VisualSonics, a developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, announced that it has sold its 200th VevoT platform.  The company feels that its success is indicative of the significant demand for micro-ultrasound technology within biotechnology, pharmaceutical and medical research organizations. Another sign? The company said that it saw quarterly revenues of a few hundred thousand dollars in 2003. Now VisualSonics is experiencing a 145 percent compounded annual growth rate, quickly reaching its current $24 million in annualized sales, according to a release.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.